TY  - JOUR
AU  - Gil Ordóñez, Ana
AU  - Martín-Fontecha Corrales, María Del Mar
AU  - Ortega Gutiérrez, Silvia
AU  - López Rodríguez, María Luz
PY  - 2018
DO  - 10.1016/j.bcp.2018.07.036
SN  - 0006-2952
UR  - https://hdl.handle.net/20.500.14352/13001
T2  - Biochemical Pharmacology
AB  - Monoacylglycerol lipase (MAGL) has been characterized as the main enzyme responsible for the inactivation of the most abundant brain endocannabinoid, 2-arachidonoylglycerol (2-AG). Besides this role, MAGL has progressively acquired a growing...
LA  - eng
M2  - 18
PB  - Elsevier
KW  - Monoacylglycerol lipase
KW  - MAGL
KW  - Endogenous cannabinoid system
KW  - MAGL inhibitors
KW  - Endocannabinoids2-Arachidonoylglycerol
TI  - Monoacylglycerol lipase (MAGL) as a promising therapeutic target
TY  - journal article
VL  - 157
ER  -